Aurélie Garant

1.5k total citations
66 papers, 958 citations indexed

About

Aurélie Garant is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Aurélie Garant has authored 66 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 21 papers in Radiation and 20 papers in Oncology. Recurrent topics in Aurélie Garant's work include Advanced Radiotherapy Techniques (21 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Colorectal Cancer Surgical Treatments (14 papers). Aurélie Garant is often cited by papers focused on Advanced Radiotherapy Techniques (21 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Colorectal Cancer Surgical Treatments (14 papers). Aurélie Garant collaborates with scholars based in United States, Canada and France. Aurélie Garant's co-authors include T. Vuong, Raquibul Hannan, Neil Desai, Robert Timmerman, Gina Brown, Chris Hunter, Giovanni Artho, Paris Tekkis, Zoë R. Greenwald and Claudine Guilbault and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Aurélie Garant

55 papers receiving 945 citations

Peers

Aurélie Garant
Amy Chang China
Cees Verhoef Netherlands
Carla Hajj United States
R. Semrau Germany
Renuka Malik United States
Stephanie Kroeze Switzerland
Tithi Biswas United States
Claudio V. Sole Spain
Li-Zhi Liu China
Keith Unger United States
Amy Chang China
Aurélie Garant
Citations per year, relative to Aurélie Garant Aurélie Garant (= 1×) peers Amy Chang

Countries citing papers authored by Aurélie Garant

Since Specialization
Citations

This map shows the geographic impact of Aurélie Garant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Garant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Garant more than expected).

Fields of papers citing papers by Aurélie Garant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Garant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Garant. The network helps show where Aurélie Garant may publish in the future.

Co-authorship network of co-authors of Aurélie Garant

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Garant. A scholar is included among the top collaborators of Aurélie Garant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Garant. Aurélie Garant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yen, Allen, Shanshan Tang, Alana Christie, et al.. (2025). Predictive Factors for Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Radiation: A Retrospective Study. European Urology Oncology. 8(5). 1237–1247.
2.
3.
Shen, Chenyang, T. Banks, Hao Peng, et al.. (2025). Expanding SCINTIX Biology-Guided Radiotherapy Beyond Lung and Bone: A Planning Feasibility and Dosimetric Study on the RefleXion X1 System. Technology in Cancer Research & Treatment. 24. 2244107222–2244107222.
4.
Venkatesulu, Bhanu Prasad, William G. Adams, Clive R.G. Quick, et al.. (2025). The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 122(5). 1186–1191. 1 indexed citations
5.
Hwang, Lindsay, Suzanne Cole, Anishka D'souza, et al.. (2025). Safety of combining radiotherapy and antibody drug conjugates in advanced urothelial and other cancers.. Journal of Clinical Oncology. 43(5_suppl). 758–758. 1 indexed citations
6.
Aliru, Maureen, Song Zhang, Jue Wang, et al.. (2024). Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates.. Journal of Clinical Oncology. 42(16_suppl). 5078–5078.
7.
Adams, William G., Ahmer Farooq, Aurélie Garant, et al.. (2024). Initial Results of a Multi-Institutional Phase 1/2 Trial of Focal Dose-Escalated Salvage High Dose Rate Brachytherapy for Radiorecurrent Prostate Cancer (F-SHARP). International Journal of Radiation Oncology*Biology*Physics. 120(2). S125–S126. 1 indexed citations
8.
Costa, Daniel N., Nghi Nguyen, Aurélie Garant, et al.. (2024). The role of the radiologist in the prostate cancer multidisciplinary conference. Abdominal Radiology. 49(11). 4162–4172.
9.
Hannan, Raquibul, Mark F. McLaughlin, Laurentiu M. Pop, et al.. (2023). Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. European Urology. 84(3). 275–286. 27 indexed citations
10.
Vitzthum, Lucas K., Daniel T. Chang, Michael F. Gensheimer, et al.. (2023). Analysis of the Measured FDG Uptake from the First-in-Human Clinical Trial of Biology-Guided Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 117(2). e61–e62.
11.
Adams, William, Elai Davicioni, Steven M. Shea, et al.. (2023). F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer. British Journal of Urology. 133(2). 188–196. 4 indexed citations
12.
Lin, Mu‐Han, et al.. (2022). Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer. Frontiers in Oncology. 12. 898822–898822. 4 indexed citations
13.
Vuong, T., Aurélie Garant, V. Vendrely, André‐Guy Martin, & Slobodan Dević. (2022). Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer. Cancer/Radiothérapie. 26(6-7). 879–883. 1 indexed citations
14.
Hannan, Raquibul, Samer Salamekh, Neil Desai, et al.. (2021). SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial. International Journal of Radiation Oncology*Biology*Physics. 113(2). 290–301. 20 indexed citations
15.
All, Sean, Aurélie Garant, & Raquibul Hannan. (2021). Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC. Seminars in Radiation Oncology. 31(3). 227–234. 13 indexed citations
16.
Garant, Aurélie, Petr Kavan, André‐Guy Martin, et al.. (2020). Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial. Radiotherapy and Oncology. 155. 237–245. 17 indexed citations
17.
Garant, Aurélie, Slobodan Dević, André‐Guy Martin, et al.. (2019). Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(5). 1005–1011. 29 indexed citations
18.
Zhang, Yuanyuan, Jonathan E. Schoenhals, Alana Christie, et al.. (2019). Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(2). 367–375. 68 indexed citations
19.
Garant, Aurélie, et al.. (2016). Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity. Cureus. 8(1). e455–e455. 1 indexed citations
20.
Hunter, Chris, Aurélie Garant, T. Vuong, et al.. (2011). Adverse Features on Rectal MRI Identify a High-risk Group that May Benefit from More Intensive Preoperative Staging and Treatment. Annals of Surgical Oncology. 19(4). 1199–1205. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy Chang Breakdown of academic impact, for papers by Cees Verhoef Breakdown of academic impact, for papers by Carla Hajj Breakdown of academic impact, for papers by R. Semrau Breakdown of academic impact, for papers by Renuka Malik Breakdown of academic impact, for papers by Stephanie Kroeze Breakdown of academic impact, for papers by Tithi Biswas Breakdown of academic impact, for papers by Claudio V. Sole Breakdown of academic impact, for papers by Li-Zhi Liu Breakdown of academic impact, for papers by Keith Unger
Rankless by CCL
2026